Related references
Note: Only part of the references are listed.Novel non-viral gene delivery systems composed of carbosilane dendron functionalized nanoparticles prepared from nano-emulsions as non-viral carriers for antisense oligonucleotides
Cristina Fornaguera et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Fabrication of Corona-Free Nanoparticles with Tunable Hydrophobicity
Daniel F. Moyano et al.
ACS NANO (2014)
Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?
Joerg Kreuter
ADVANCED DRUG DELIVERY REVIEWS (2014)
Optimizing the selective recognition of protein isoforms through tuning of nanoparticle hydrophobicity
Kaimin Chen et al.
NANOSCALE (2014)
Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery
Julien Nicolas et al.
CHEMICAL SOCIETY REVIEWS (2013)
Effects of Particle Size and Surface Modification on Cellular Uptake and Biodistribution of Polymeric Nanoparticles for Drug Delivery
Sneha A. Kulkarni et al.
PHARMACEUTICAL RESEARCH (2013)
Accumulated Polymer Degradation Products as Effector Molecules in Cytotoxicity of Polymeric Nanoparticles
Raman Preet Singh et al.
TOXICOLOGICAL SCIENCES (2013)
A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines
Janos Szebeni et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Nanotheranostics for personalized medicine
Simona Mura et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres
R. Gref et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Nano-emulsions: Formation by low-energy methods
Conxita Solans et al.
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE (2012)
Effects of block copolymer properties on nanocarrier protection from in vivo clearance
Suzanne M. D'Addio et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Poly(isobutylcyanoacrylate) Nanoparticles Decorated with Chitosan: Effect of Conformation of Chitosan Chains at the Surface on Complement Activation Properties
Christelle Zandanel et al.
JOURNAL OF COLLOID SCIENCE AND BIOTECHNOLOGY (2012)
Material properties in complement activation
S. Moein Moghimi et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Protein adsorption and complement activation for di-block copolymer nanoparticles
Christine Vauthier et al.
BIOMATERIALS (2011)
Variable Antibody-dependent Activation of Complement by Functionalized Phospholipid Nanoparticle Surfaces
Christine T. N. Pham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Effect of thiol functionalization on the hemo-compatibility of PLGA nanoparticles
Y. M. Thasneem et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2011)
Formation of polymeric nano-emulsions by a low-energy method and their use for nanoparticle preparation
Gabriela Caldero et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2011)
Pathogen-mimetic stealth nanocarriers for drug delivery: a future possibility
Miguel Cavadas et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Biodegradable polymeric nanoparticles based drug delivery systems
Avnesh Kumari et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups
Carolina Salvador-Morales et al.
BIOMATERIALS (2009)
Configuration of bovine serum albumin adsorbed on polymer particles with grafted dextran corona
Christine Vauthier et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2009)
Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles
Marina A. Dobrovolskaia et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2009)
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
Christine Vauthier et al.
PHARMACEUTICAL RESEARCH (2009)
Active targeting schemes for nanoparticle systems in cancer therapeutics
James D. Byrne et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate
Elisabetta Cenni et al.
BIOMATERIALS (2008)
Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution
Marina A. Dobrovolskaia et al.
MOLECULAR PHARMACEUTICS (2008)
Protein-nanoparticle interactions
Iseult Lynch et al.
NANO TODAY (2008)
Sizing up targets with nanoparticles
Rod Minchin
NATURE NANOTECHNOLOGY (2008)
Immunological properties of engineered nanomaterials
Marina A. Dobrovolskaia et al.
NATURE NANOTECHNOLOGY (2007)
Measurement and interpretation of electrokinetic phenomena
A. V. Delgado et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2007)
Targeting of nanoparticles to the clathrin-mediated endocytic pathway
Oshrat Harush-Frenkel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Parameters influencing the stealthiness of colloidal drug delivery systems
Arnaud Vonarbourg et al.
BIOMATERIALS (2006)
Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: Influences of surface morphology, length, and type of polysaccharide
Isabelle Bertholon et al.
PHARMACEUTICAL RESEARCH (2006)
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles
Catarina Pinto Reis et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2006)
In vitro studies of the hemolytic activity of microemulsions in human erythrocytes
RM Aparicio et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2005)
Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush
D Labarre et al.
BIOMATERIALS (2005)
Interaction of PLGA nanoparticles with human blood constituents
D Kim et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2005)
Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules
VCF Mosqueira et al.
BIOMATERIALS (2001)
Share Paper
